Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 167 institutions that hold shares in the stock, with a total of 78.3 Million shares, which have been reported (via 13F filing form) to have a value of $509 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
600,000
shares
|
$3.9 Million
0.86% of portfolio
|
Q3 2024
New holding
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
545,751
shares
|
$3.55 Million
0.64% of portfolio
|
Q3 2024
Added 39.84%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
542,846
shares
|
$3.53 Million
0.0% of portfolio
|
Q3 2024
Added 458.61%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
487,000
shares
|
$3.17 Million
4.11% of portfolio
|
Q3 2024
Added 31.88%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
479,500
shares
|
$3.12 Million
0.01% of portfolio
|
Q3 2024
Added 448.0%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
463,875
shares
|
$3.02 Million
0.0% of portfolio
|
Q3 2024
Added 33.39%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
456,939
shares
|
$2.97 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
449,321
shares
|
$2.92 Million
1.12% of portfolio
|
Q3 2024
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
418,867
shares
|
$2.72 Million
0.0% of portfolio
|
Q3 2024
Reduced 40.05%
|
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Oct 15, 2024 Q3 2024 |
376,600
shares
|
$2.45 Million
0.1% of portfolio
|
Q3 2024
Added 1.35%
|
|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
330,000
shares
|
$2.15 Million
0.97% of portfolio
|
Q3 2024
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
308,497
shares
|
$2.01 Million
0.45% of portfolio
|
Q3 2024
Reduced 32.72%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 12, 2024 Q3 2024 |
303,916
shares
|
$1.98 Million
0.03% of portfolio
|
Q3 2024
Added 801.21%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
301,224
shares
|
$1.96 Million
0.02% of portfolio
|
Q3 2024
Reduced 59.57%
|
|
|
Telemark Asset Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
300,000
shares
|
$1.95 Million
0.27% of portfolio
|
Q3 2024
New holding
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2024 Q3 2024 |
300,000
shares
|
$1.95 Million
0.29% of portfolio
|
Q3 2024
New holding
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
244,576
shares
|
$1.59 Million
0.0% of portfolio
|
Q3 2024
Reduced 17.95%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
222,065
shares
|
$1.44 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.94%
|
|
|
J. Goldman & CO LP
New York, NY |
Nov 14, 2024 Q3 2024 |
203,941
shares
|
$1.33 Million
0.05% of portfolio
|
Q3 2024
New holding
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
202,348
shares
|
$1.32 Million
0.98% of portfolio
|
Q1 2023
New holding
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
186,578
shares
|
$1.21 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
185,795
shares
|
$1.21 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Cinctive Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
168,564
shares
|
$1.1 Million
0.08% of portfolio
|
Q3 2024
New holding
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
157,786
shares
|
$1.03 Million
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
154,714
shares
|
$1.01 Million
0.0% of portfolio
|
Q3 2024
Added 1.31%
|